The contribution of LDG to the clinical phenotype of patients with anti-MDA5 antibodies is especially interesting, since the MDA5 phenotype is characterized by rapidly progressive ILD (64) and intense vasculopathy manifested as cutaneous ulcers and necrosis (65). This evidence concerns the gene IFIH1 and vascular disorder.